AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

RecruitingNAAges 18 Years - anyAllFirst Affiliated Hospital of Shantou University Mโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a prospective, multi-center, randomized controlled trial. The subjects are patients scheduled to undergo a combined procedure of atrial fibrillation (AF) ablation and left atrial appendage (LAA) occlusion. After signing the informed consent form, the subjects will be randomly assigned to either the cardiac Computed Tomography (CT) group or the Digital Subtraction Angiography (DSA) group. The operator will select the appropriate LAA occluder size for implantation based on different measurement methods. All subjects will undergo clinical follow-up before discharge and at 3 months postoperatively, as well as telephone follow-up 1-5 years after the surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age โ‰ฅ 18 years; 2. Patients with non-valvular atrial fibrillation scheduled to undergo atrial fibrillation ablation and percutaneous left atrial appendage occlusion; 3. Able to understand the purpose of the trial, willing to participate in the study, and the subject or their legal representative has signed the informed consent form, and is willing to complete the follow-up according to the protocol requirements. Exclusion Criteria: 1. Allergy to contrast agents or other conditions that preclude cardiac CT or DSA imaging; 2. Absence of clear images for measuring the diameter of the LAA in all layers of the CT scan; 3. Imaging indicates the presence of thrombus in the left atrium or LAA; 4. Patients with valvular AF (mechanical valve replacement or moderate to severe mitral stenosis combined with AF); 5. LAA depth \< 15 mm, or LAA anchor zone diameter \< 10 mm or \> 33 mm; 6. Female patients of childbearing age planning to become pregnant during the follow-up period required by this study; 7. Currently participating in another clinical trial of drugs or medical devices and has not yet completed the primary endpoints of that study, which may confound the results of this study or affect the participant's compliance with the follow-up; 8. Other conditions that the investigator deems make the participant unsuitable for this study.
๐Ÿ’Š

What it tests

  • CT group
  • DSA group
๐Ÿ“

Where

5 sites
Foshan Nanhai District People's Hospital
Foshan, China
The Second People's Hospital of Foshan
Foshan, China
Meizhou Hospital of Traditional Chinese Medicine
Meizhou, China
First Affiliated Hospital of Shantou University Medical College
Shantou, China
Guangdong Provincial Zhongshan Hospital of Traditional Chinese Medicine
Zhongshan, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy